ALNY
Alnylam Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Alnylam Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Alnylam Pharmaceuticals, Inc.
165.53
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $4.5B | 11.10% | +3.05% | |
| 2 | Capital World InvestorsCapital World Investors | $3.4B | 8.23% | +3.17% | |
| 3 | BlackRockBlackRockindex-like | $3.3B | 8.06% | +4.43% | |
| 4 | Capital Research Global InvestorsCapital Research Global Investors | $2.9B | 7.20% | +2.95% | |
| 5 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $2.0B | 4.83% | +0.73% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $1.8B | 4.45% | +1.39% | |
| 7 | T. Rowe Price Investment ManagementT. Rowe Price | $1.7B | 4.17% | +8.64% | |
| 8 | InvescoInvesco | $1.1B | 2.77% | −7.87% | |
| 9 | State StreetState Streetindex-like | $1.1B | 2.63% | +7.01% | |
| 10 | Geode Capital ManagementGeodeindex-like | $791.3M | 1.94% | −0.92% | |
| 11 | JPMorgan ChaseJPMorgan Chase | $785.3M | 1.93% | −57.69% | |
| 12 | Baillie GiffordBaillie Gifford | $734.5M | 1.80% | −2.16% | |
| 13 | Norges BankNorges Bankindex-like | $683.9M | 1.68% | — | |
| 14 | Wellington Management GroupWellington | $635.3M | 1.56% | +9.01% | |
| 15 | Orbis Allan GrayOrbis Allan Gray | $598.3M | 1.47% | +48.89% | |
| 16 | Dodge & COXDodge & COX | $588.6M | 1.44% | +1.35% | |
| 17 | Two Sigma InvestmentsTwo Sigma | $564.7M | 1.39% | −5.85% | |
| 18 | American Century CompaniesAmerican Century Companies | $558.1M | 1.37% | +2.86% | |
| 19 | D. E. ShawD. E. Shaw | $461.9M | 1.13% | +4.07% | |
| 20 | Clearbridge InvestmentsClearbridge | $379.1M | 0.93% | −7.12% | |
| 21 | T. Rowe Price AssociatesT. Rowe Price | $345.9M | 0.85% | −19.79% | |
| 22 | Morgan StanleyMorgan Stanley | $310.7M | 0.76% | +2.94% | |
| 23 | Bank of AmericaBank of America | $299.4M | 0.73% | +2.85% | |
| 24 | Legal & General GroupLegal & General | $278.3M | 0.68% | −1.10% | |
| 25 | Manufacturers Life Insurance Company, theManufacturers Life Insurance Company, the | $269.1M | 0.66% | +34.94% |
796 managers report $40.8B of Alnylam Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 36 of them hold 80% of it; FMR is largest at 11.10%.
Expected move
No implied move.
No implied move.
No implied move.
Linked news